InvestorsHub Logo
Followers 240
Posts 24538
Boards Moderated 3
Alias Born 12/27/2006

Re: Iam_in post# 527

Friday, 11/15/2019 8:08:19 PM

Friday, November 15, 2019 8:08:19 PM

Post# of 834
 Oragenics is currently pursuing the commercial-scale production of a lantibiotic for use as an antimicrobial targeting Clostridium difficileassociated disease, the most prevalent hospital-acquired infection.

All of this is my opinion only and should not be construed as investment advice.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OGEN News